ADHD Medications · Strattera, Adderall, Ritalin, Vyvanse, Concerta
ADHD Medication Not Working? What Your DNA Might Have to Do With It
Stimulants are not strongly affected by pharmacogenetics, but atomoxetine is a different story. One enzyme, CYP2D6, goes a long way toward explaining why some people respond and others don't.
Finding the right ADHD medication is mostly trial and error. If stimulants like Adderall or Ritalin aren't working, or if Strattera hasn't helped, genetics is one of the things worth checking. Stimulants aren't strongly affected by pharmacogenetics, but the non-stimulant atomoxetine (Strattera) is one of the more genetically sensitive psychiatric drugs in common use. CYP2D6 status alone goes a long way toward explaining why some people respond and others don't.
40% of people carry CYP2D6 variants meaningful enough to change how atomoxetine should be dosed
Common reasons this happens
The Medication May Need More Time or Dose Adjustment
Stimulant medications (Adderall, Ritalin, Vyvanse, Concerta) usually start working within hours but often need dose fine-tuning. Non-stimulant medications like atomoxetine (Strattera) take 4-8 weeks to reach full effect. If you recently started or changed medications, it may just be too early to judge.
The Wrong Type of ADHD Medication
There are two main classes of ADHD medication: stimulants (methylphenidate-based like Ritalin/Concerta and amphetamine-based like Adderall/Vyvanse) and non-stimulants (atomoxetine, guanfacine, clonidine). Some people respond well to one class but not the other. If one stimulant type doesn't work, the other type sometimes does.
Coexisting Conditions
ADHD often coexists with anxiety, depression, sleep disorders, and learning disabilities. When those aren't addressed, they can make it look like the ADHD medication isn't working. Anxiety in particular can imitate or worsen ADHD symptoms and may need its own treatment.
Medication Tolerance
Some people develop tolerance to stimulant medications over time and end up needing dose adjustments. Drug holidays (supervised breaks from medication) or switching between stimulant types can sometimes help reset tolerance.
Roughly 40 percent of people carry CYP2D6 variants meaningful enough to change how atomoxetine should be dosed. That's a lot of people for a single enzyme.
How your genetics can play a role
The pharmacogenetic story for ADHD is mostly about non-stimulants. Atomoxetine has one of the clearest gene-drug relationships of any psychiatric medication,[1] and roughly 40 percent of people carry CYP2D6 variants meaningful enough to change how it should be dosed. That's a lot of people for a single enzyme.
| Gene | What it affects |
|---|---|
| CYP2D6 | CYP2D6 is the primary enzyme that metabolizes atomoxetine.[1] It's also one of the most variable genes in the genome. Poor metabolizers (5-10% of Caucasians) end up with significantly higher atomoxetine blood levels, which can mean better symptom control but also more side effects. Ultrarapid metabolizers (1-2%) clear the drug so quickly that standard doses often miss therapeutic range. These are among the strongest pharmacogenetic associations in psychiatry.[2] |
For atomoxetine, CYP2D6 ultrarapid metabolizers often need doses above the standard maximum to hit therapeutic blood levels.[1] Poor metabolizers usually need lower doses than typical and may respond well to what would otherwise look like an inadequate dose. If your doctor has been adjusting your atomoxetine dose without much success, CYP2D6 testing can reveal whether the dosing strategy needs to be different based on your genetic profile.[3] For stimulant medications, the pharmacogenetic impact is smaller, but CYP2D6 testing is still useful because it informs dosing for many other medications you may take now or down the road.
Want to know what your genetics say about how you'll respond to Atomoxetine?
A Gene2Rx report reads your own DNA to show how it may affect your response to Atomoxetine and your other medications.
Find out todayWhen to consider pharmacogenetic testing
Pharmacogenetic testing is especially useful for ADHD if you've tried atomoxetine without the expected results (either poor efficacy or excess side effects), if you've cycled through multiple ADHD medications without finding a good fit, or if you're managing ADHD alongside depression or anxiety (where CYP2C19 and CYP2D6 both matter for antidepressant selection).
What you can do next
- Work with your doctor to systematically evaluate your current medication before switching.
- If you're on atomoxetine, consider CYP2D6 pharmacogenetic testing to see whether your dose needs adjustment based on your metabolizer status.
- Track your ADHD symptoms with a rating scale or daily log. Memory alone is unreliable for judging whether a medication is actually helping.
- Talk through whether coexisting conditions like anxiety, depression, or sleep problems need their own treatment.
- Ask about combination approaches if a single medication isn't enough on its own.
Related medications
Related guides
- Atomoxetine Not Working? Why Strattera Might Not Be Helping Your ADHD
- 23andMe Pharmacogenetics: How to Get a Drug Response Report From Your Existing Data
- AncestryDNA for Drug Testing: Get Pharmacogenetics From Your Ancestry Data
- Looking for a GeneSight Alternative? Here's the Short Answer
- How Much Does GeneSight Cost? Full Breakdown Plus Alternatives
- GeneSight vs Genomind vs Gene2Rx: Three-Way Pharmacogenetic Test Comparison
Frequently asked questions
Do genetics affect stimulant ADHD medications like Adderall?
The pharmacogenetic effect on stimulants is much smaller than for atomoxetine. Stimulants work through dopamine and norepinephrine release rather than being metabolized by a single variable enzyme. Your overall pharmacogenetic profile can still inform decisions about non-stimulant alternatives and any co-prescribed medications.
How common is it for the first ADHD medication not to work?
Very common. Studies suggest stimulants have a 70-80% response rate as a class, but the first specific medication tried may only work for about 50-60% of patients. Most people need some trial and adjustment to land on the right medication and dose.
Can pharmacogenetic testing help with ADHD medication for children?
Yes. The same CYP2D6 variations affect children just as much as adults. Testing can be especially useful for children to avoid unnecessary medication trials and side effects. If atomoxetine is on the table, CYP2D6 testing can guide dosing from the start.
References
- CPIC. CPIC Guideline for Atomoxetine and CYP2D6 (2019). cpicpgx.org
- U.S. Food and Drug Administration. Table of Pharmacogenomic Biomarkers in Drug Labeling (2024). fda.gov
- Clinical Pharmacogenetics Implementation Consortium (CPIC). CPIC Guidelines. cpicpgx.org
Disclaimer: This content is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your healthcare provider before making changes to your medication. Never stop or change a medication without medical supervision.